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(EchoNoRMAL) Collaboration
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Aim To develop age-, sex-, and ethnic-appropriate normative reference ranges for standard echocardiographic measure-
ments of the left heart by combining echocardiographic measurements obtained from adult volunteers without clinical
cardiovascular disease or significant cardiovascular risk factors, from multiple studies around the world.
Methods
and results
The EchocardiographicNormal RangesMeta-Analysis of the Left heart (EchoNoRMAL) collaborationwas established and
population-based data sets of echocardiographicmeasurements combined to perform an individual person datameta-ana-
lysis. Data from 43 studies were received, representing 51 222 subjects, of which 22 404 adults aged 18–80 years were
without clinical cardiovascularor renal disease, hypertensionor diabetes.Quantile regressionor an appropriate parametric
regression method will be used to derive reference values at the 5th and 95th centile of each measurement against age.
Conclusion This uniquedata set represents a large,multi-ethnic cohort of subjects resident in awide rangeof countries. The resultant
reference ranges will have wide applicability for normative data based on age, sex, and ethnicity.
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Background
Theclinical valueof echocardiography (echo), orany imagingmodality,
relies on its ability to detect abnormalities. However, the diagnosis of
‘abnormal’ depends on the definition of ‘normal’. Themost recent ref-
erence values for echo chamber quantification were jointly published
by theAmericanSocietyof Echocardiography (ASE) andEuropeanAs-
sociationofCardiovascular Imaging (EACVI) in 2006.1 This reportwas
an important advance in quantitative echo in terms of consensus;
however, the reference ranges were based upon a mixture of expert
opinion, published and unpublished data, and a range of approaches
to define the reference values. As reference values are inherently de-
pendent upon the individual subjects studied, the population from
which they are drawn is critical. In the joint ASE/EACVI report,1 the
ranges presented for left ventricular (LV) quantification were typically
developed from relatively small North American cohorts recruited in
the 1970s–80s and therefore may not represent the diverse world
population to which they are now applied.
In supportof this concern, a systematic reviewof the literature2 iden-
tified that LV mass varied between normal cohorts from around the
world. Individual values commonly fell outside the ASE/EACVI
reference ranges,1 whether indexed for body size or not. Ideally, sex-
and ethnic-specific reference ranges should be developed using geo-
graphically diverse and population-based echo studies. As this has
never been done before, we recently established a global collaborative
initiative and here describe theobjectives andmethods of this initiative.
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Study objective
Our primary objective is to develop age-, sex-, and ethnic-appropriate
normative reference ranges for standard echo measurements of the
left heart by combining echo measurements obtained from adult
volunteerswithout clinical cardiovascular disease (CVD) or significant
cardiovascular risk factors, resident in a wide range of countries. This
will be achieved through an individual person data meta-analysis.
Study design
Identification of cohorts
Population-based cohorts with echo measurements were identified
through comprehensive literature searches, a published research
call,3 and personal communication.
Two literature searches were performed. The first was under-
taken to identify studies that used echo in healthy volunteers. The
second identifiedpopulation studies inwhich echowas used todocu-
ment the prevalence of a disease but for which echo findingsmay not
have been published.
Studies were identified by searching Medline, Embase, and Scopus
databases. The primary search used the keywords: echo with or
without:Doppler, colour, stress, three-dimensional, four-dimensional;
reference: values, ranges, limits; normal: ranges, values; atrial: dimen-
sion, volume, structure, function; ventricular: dimension, volume,
mass, structure, function. In addition, the population search used the
keywords: epidemiology, cohort, cross-sectional, sample studies;
mass screening, anonymous testing,multiphasic screening; and supple-
mentaryconcept termsofpopulation:based, study, studies.Whereap-
plicable, keywords were searched as the root and truncation symbol
(e.g. ventric*). All searches were limited to humans and studies pub-
lished between 1 January 1990 and 31 December 2011. The language
of publicationwas not restricted; however, abstractswere required to
be in English. The corresponding authorwas emailedwith an invitation
to submit individual person-level data and so collaborate in the Echo-
NoRMAL meta-analysis. All individual studies were approved by ap-
propriate ethics committees, and the EchoNoRMAL protocol was
approved by the University of Auckland Human Participants Ethics
Committee (#7653).
Study inclusion criteria
Studies that recruited .50 volunteers aged ≥18 years were eligible
for inclusion. Of these, studies of special populations such as athletes
or pregnant women were excluded. Studies must have measured at
least one of LV size or mass, left atrial size, mitral inflow or tissue
Doppler, or pulmonary vein Doppler and used at least onemeasure-
ment modality of M-mode, two- (2D), or three-dimensional (3D)
echocardiography.
Studies that included patients referred for echo, but who were
later judged to have been free of the disease of interest, were not eli-
gible for inclusion. This exclusion was on the basis that the referral
may have been due to cardiac symptoms or risk factors even if no
disease was detected. Such cohorts may include patients extracted
from an echo laboratory database and retrospectively deemed
‘healthy normal’. However, studies containing patients referred to
specialist cardiac services for routine asymptomatic reasons, such
as screening for medical insurance or a ‘healthy heart check’ and
found to be free of cardiovascular or other disease, were included.
The studies included in EchoNoRMAL are described in Table 1
and Supplementary data online.
Data management
De-identified individual person data were sent to the central co-
ordinating centre located in Auckland, New Zealand, and stored
on a secure server. Each data set was reviewed for units and
methods of measurement, range checks were performed to identify
and exclude biologically implausible values, and summary statistics
cross-checked against published results, where available. Variables
were re-coded to a central legend to allow data amalgamation.
Study investigators were contacted to clarify any uncertainty about
the data or methods.
Additional variables were created to describe: the year or range of
years in which echocardiogramswere performed, themodel of echo
machine used, if echocardiograms were performed at a single centre
or not, and if image measurements were performed by a single or
multiple observers. For chamber dimensions, themeasuring conven-
tion used (leading-edge-to-leading-edge, Penn, or 2D-linear), as well
as the echocardiographic view (parasternal long axis, parasternal
short axis, apical 4- or 2-chamber) was defined for each variable.
LV volumes andmasswere defined as being derived fromdimensions
or from areas traced from 2D images, and the equation used to esti-
mate volume or mass was defined.
Ethnicity
To enable the reference ranges derived in this study to be applied in
the clinical setting, thedefinitionof raceor ethnicity needs to be care-
fully considered. Race is viewed as having a biological basis, whereas
ethnicity embodies one or more of the following: ‘shared origins or
social background; shared culture and traditions that are distinctive,
maintained between generations, and lead to a sense of identify and
group; and a common language or religious tradition’.40
Awide rangeof ethnic groupsweredescribedby individual studies,
with definitions on the basis of self-identification (16 studies), ances-
try (1 study), or by name and country of recruitment (1 study).
Twenty-five studies did not state how ethnicity was defined. Race
may be the more appropriate concept by which to discuss cardiac
size and function in health; however, ethnicity is typically self-
identified and therefore the most accessible definition in practice.
The data available to the meta-analysis were centred on ethnicity.
Consequently, the ethnic groups described by individual studies
have been grouped as follows:African: African, African-Caribbean,
Black (not American), Black African, Black British, Black Caribbean,
Brazilian-Mulatto, Nigerian, Somali; American Black: African
American, Black (American studies); Asian: Asian, Asiatic,
Chinese, East Timorese, Filipino, Japanese, Korean, Malaysian, Tai-
wanese, Thai, Tibetan, or Vietnamese; Australian Aboriginal;
European: white European or Caucasian described as American,
Australian, Belgian, British, Bulgarian, Caucasian Jew, Croatian,
Czech, Danish, French, Greek, Italian, Latin American, Maltese,
New Zealander, Polish, Scandinavian, Serbian, South African,
Spanish, or Turkish; Middle Eastern: Arab, Iranian; Pacific:
Maori, Samoan; South Asian: Bangladeshi, British South Asian,
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Table 1 EchoNoRMAL studies and investigators
Study Investigators
Alberta HEARTa T. Anderson, J. Dyck, J. A. Ezekowitz
Asklepios4 J. A. Chirinos, M. L. De Buyzere, T. C. Gillebert, E. Rietzschel, P. Segers, C. M. Van Daele
Aucklanda R. N. Doughty, K. K. Poppe, H. A. Walsh, G. A. Whalley
Campania Salute5 R. Izzo, N. De Luca, B. Trimarco, G. de Simone
CARDIA6 Restricted public use data
CCCC7 P. -C. Chen, K. -L. Chien, H. -J. Lin, T. -C. Su
CCHS8 R. Mogelvang, J. Skov Jensen
Chadha9 D. S. Chadha, K. Goel, A. Misra
China California Heart Watch10 R. Detrano, www.chinacal.org
Christchurch Healthy Volunteersa V. Cameron, A. M. Richards, R. Troughton
CHS6 Restricted public use data
Di Pasquale11 P. Di Pasquale, S. Paterna
Duzenli12 M. Akif Duzenli
ECHOES13 F. D. R. Hobbs, M. K. Davies, R. C. Davis, A. Roalfe
E-ECHOES14 M. Calvert, M. K. Davies, R. C. Davis, N. Freemantle, P. S. Gill, G. Y. H. Lip
FLEMENGHO15 T. Kuznetsova, J. A. Staessen
Glasgow MONICA16 H. J. Dargie, I. Ford, T. A. McDonagh, J. J. V. McMurray
Grossman17 E. Grossman
Harrow Heart Failure Watch18 G. Galasko, A. Lahiri, R. Senior
Heart of Soweto19 L. Blauwet, K. Sliwa, S. Stewart
Heart of the Heart20 A. Brown, M. Carrington, H. Krum, M. McGrady, S. Stewart, C. Zeitz
HUNT21 H. Dalen, H. E. Moelmen Hansen, A. Støylen, A. Thorstensen
JAMP22 M. Daimon, H. Watanabe, J. Yoshikawa
JAMP-3D23 S. Fukuda
Kim24 H. -K. Kim
Leung25 N. K. W. Leung
Linhart26 A. Linhart
LOLIPOP27 N. Chahal, J. C. Chambers, J. Kooner, R. Senior
NEAT28 J. Davies, I. Loke, L. Ng, I. B. Squire
NEST29 E. Aune, J. E. Otterstad
Ng30 D. Y. Leung, A. C. T. Ng
Ojji31 D. Ojji
OxVALVEa L. Arnold, S. Coffey, J. d’Arcy, C. Hammond, C. Mabbett, C. Lima, M. Loudon, N. Pinheiro, B. Prendergast, R. Reynolds
Padua 3D Echo Normal32 L. P. Badano, D. Muraru, D. Peluso, L. Dal Bianco
Petrovic33 D. J. Petrovic, J. Petrovic
Schvartzman34 P. Schvartzman, F. D. Fuchs
Simovaa T. Katova, I. Simova
Takeuchi35 K. Kaku, M. Takeuchi
Thomas36 A. Boyd, L. Thomas
Thomas 2a E. M. Chia, L. Thomas
Tromsø Study37 H. Schirmer
Vitoria Brazil38 L. C. Angelo, A. C. Pereira, J. E. Krieger, J. G. Mill, S. L. Rodrigues
Vobarno39 M. L. Muiesan, A. Paini, E. Agabiti Rosei, M. Salvetti
aUnpublished data.
CARDIA, Coronary Artery Risk Development in Adults; CCCC, Chin-Shan Community Cardiovascular Cohort study; CCHS, Copenhagen City Heart Study; CHS, Cardiovascular
Health Study; ECHOES, Echocardiographic Heart of England Screening; E-ECHOES, Ethnic-Echocardiographic Heart of England Screening; FLEMENGHO, Flemish Study on
Environment, Genes and Healthy Outcome; HUNT, Nord-Trøndelag Health Study; JAMP, Japanese normal values for echocardiographic Measurements Project; LOLIPOP, Life
Sciences Prospective Population Study; NEAT, New and Emerging Applications of Technology; NEST, Normal Echo Study Tønsberg.
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East African Asian, Fijian Indian, Indian, Mauritian, Pakistani, or Sri
Lankan;Other: ethnicity was not defined in the original study.
Individual participant exclusions
A flowchart showing derivation of the reference cohort is in Figure 1.
Individual study designmay have included or excluded participants
on the basis of clinically manifest disease at the point of recruitment.
Forexample, studies recruiting from the general populationmay have
included participants with a variety of common medical conditions,
and such participants cannot be included in the derivation of norma-
tive reference ranges. The initial definitions of CVD, diabetes, hyper-
tension, renal disease, or pregnancy were those determined by the
individual study investigators. Study-level definitions of CVD were
≥1 of: self-reported history including prior surgery or intervention
for coronary artery or valvular disease, physical assessment, resting
ECG, stress test, major echo findings, and permanent pacemaker
[for either bradycardia, tachycardia (including ICD), or cardiac resyn-
chronization therapy]. Excluded rhythms includedatrial fibrillationor
flutter, second- or third-degree atrioventricular block (AVB), LBBB,
or the presence of Q waves. Subjects were not excluded on the
basis of mild first-degree AVB, RBBB, non-specific ST/T wave
changes,when suchdatawere available. Study-level definitionsof dia-
betes and hypertension were based on ≥1 of: self-report, medical
record or medication use, glucose levels, or blood pressure (BP) at
the time of echo. Most of the studies used a BP threshold of .140/
90 mmHg to define hypertension. Two studies used .160/90,18,29
two used .135/85,22,23 and one used .130/85 mmHg.9
In addition to these investigator-defined exclusions, subjects with
probable diabetes, hypertension, or renal disease were excluded
based on current recommended thresholds of glucose or HbA1c,
BP, or creatinine, where available (Figure 1). Lastly, five people with
extreme outlying values of LV ejection fraction (EF, 20%) were
excluded.
The remaining 22 404 subjects form the EchoNoRMALReference
Cohort andwill be used todevelop reference values. The28 818 sub-
jects excluded from the reference cohortwill be used in sub-analyses
of the EchoNoRMALstudy.Demographic andechovariables that are
available are described in Table 2.
Analysis
Reference valueswill be derived using quantile regression41 or an ap-
propriate parametric regression method to model the relationship
between age and pre-defined centiles of each measurement (5th
and 95th centiles). Reference values will be derived from models
that represent contributing studies as a fixed effect. Study will then
be included as a random effect to assess the variation between
studies (within gender and ethnic group).
Reference values will be defined formeasurements on the basis of
imaging modality used. For example, LV mass estimated from
M-mode images will not be combined with mass from 2D images.
A rangeof indexationmethodswill be investigated formeasurements
of atrial and ventricular size, andof LVmass. This includes assessment
of the ratiometric and allometric relationships of each measurement
to height, weight, and body surface area.
As reference values are derived from the margins of the distribu-
tion, they are sensitive to variability, and for age-dependent values,
require sufficient data at each age to be representative. Therefore,
these ranges cannot be derived in sub-groups in which only a small
amount of data are available. In these cases, exploratory or descrip-
tive analyses will be undertaken to represent the data that are
Figure 1 Development of the EchoNoRMAL reference cohort CVD, cardiovascular disease; HTN, hypertension; F, fasting; NF, non-fasting;
HbA1c, glycosylated haemoglobin; BP, blood pressure; EF, left ventricular ejection fraction. *After excluding for disease, five subjects had EF of
,20% that appeared to be erroneous values.
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available, and these will highlight the need for further prospective
studies in these groups.
Hypothesis-driven secondary analyses will also be undertaken.
The approach to sub-analyses will be determined on a case-by-case
basis.
Sources of variability
Multiple levels of random variation contribute to echo measure-
ments. Factors at the level of the patient and the sonographer
cannot be assessed in a meta-analysis of data obtained from the
echo images; however, many sources of variability associated with
image measurement can be identified and potentially incorporated
into analyses (Table 3).
At the level of image measurement, human and methodological
factors contribute to variability. Visual bias may lead to consistently
larger or smaller measurements per operator, which may or may
not be similar across multiple operators within a centre. For 2D
images of the LV, for example, the selection of end-diastole and end-
systole can differ, as can recognition and tracing of the endocardial
surface. For Doppler images, the point of peak velocity within a
brightor thickenedflowprofile, or inonewithovershoot, is subjective.
Measurement protocols also differ. Linear dimensions can be mea-
sured from M-mode images using the leading-edge-to-leading-edge
convention,50 or the Penn convention,48 or they can be measured
directly from 2D images. Left heart areas or volumes can be derived
from single-plane or biplane 2D images, or from 3D images.
The conversion of measurements to estimates of area or volume
requires equations based on assumptions about the geometry of
each chamber. Different equations have been developed to allow
specificmeasurements to be used (dimension, area) and allow for dif-
fering parameterizations of the measurements (Table 3).
Study organization
The EchoNoRMAL collaboration is structured into an Executive
Group, Steering Group, Statistical Group, and a Co-ordinating
Centre. The role of each of these groups is described in Supplemen-
tary data online. Communication within and between groups is facili-
tated via teleconferences and face-to-face meetings, and regular
updates on study progress are provided to all members of the collab-
oration.
Limitations
As with any meta-analysis, the EchoNoRMAL study relies on the
extent andqualityof existingdata,whetherpublishedorunpublished.
Data may not be available for less-studied populations in the world
and although this may limit the scope of the current study, it will
serve to highlight areas that need further prospective investigation.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Subject descriptors and echocardiographic
measurements
Variable group Variables
Descriptors Age, sex, ethnicity, height, weight, BSA, BMI
Medical history Cardiovascular disease, hypertension, diabetes,
renal disease, current pregnancy
Clinical Systolic BP, diastolic BP, cholesterol, glucose,
creatinine
Aortic root Dimension
Left atrium Maximum and minimum: dimension, area,
volume, 3D volume
Left ventricle LV internal dimensions at end-diastole and
end-systole, ventricular septal thickness at
end-diastole, posterior wall thickness at
end-diastole. Fractional shortening,
EF(dimensions), LV mass, 2D and 3D LV
volumes at end-diastole and end-systole.
EF(volumes)
Mitral inflow
Doppler
E and A wave peak velocity, A wave duration,
E wave deceleration time, isovolumic
relaxation time
Mitral annular tissue
Doppler
e′, a′, and s′ peak velocities, and E/e′, at the
medial and lateral annulus.
Pulmonary vein
Doppler
Peak velocity of the S wave, D wave, A wave
reversal, duration of A reversal
Right heart Right ventricular dimension
BSA, body surface area; BMI, body mass index; BP, blood pressure; 3D,
three-dimensional; LV, left ventricle; EF, ejection fraction; E, early filling wave of
trans-mitral flow; A, late filling wave of trans-mitral flow; e′ , tissue velocity during
early filling; a′ , tissue velocity during late filling; s′ , tissue velocity during ventricular
systole; E/e′ , ratio of E wave to e′ ; S, systolic; D, diastolic; A, atrial contraction.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Variables to represent sources of variability
Variable Levels
Date of echo Year
Machine used As given
Centres Single, multiple
Measurers Single, multiple
LA dimension—
method
M-mode leading-edge-to-leading-edge
convention, M-mode Penn convention,
2D-linear
LA dimension—view Parasternal long axis, parasternal short axis,
apical 4-chamber, apical 2-chamber
LA area—view Apical 4-chamber, apical 2-chamber, apical
biplane
LAvolume—method Dimension-length,42 area-length,43 Simpson’s
biplane,44 Simpson’s single plane, 3D
LV dimension—
method
M-mode leading-edge-to-leading-edge,
M-mode Penn, 2D-linear
LV dimension—view Parasternal long axis, parasternal short axis,
apical 4-chamber, apical 2-chamber
LV volume—method
(dimensions)
Teichholz45
LV volume—method
(area)
Simpson’s biplane, Simpson’s single plane,
area-length, 46 3D
LV mass—method M-mode, leading-edge-to-leading-edge,47
2D-linear dimensions, M-mode, Penn,48
2D-linear dimensions, Penn, area-length
Reichek49
Only equations used in studies included in this meta-analysis are listed.
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The derivation of a reference cohort for development of norma-
tive reference ranges is reliant on identification of clinically manifest
CVor renal disease, hypertension, and diabetes. The focus of individ-
ual studies will differ and the extent and accuracy of screening for
disease will vary. Similarly, the definition of disease will vary
between studies. We have accounted for this by introducing a
second tier of exclusion criteria based on continuous values of BP,
blood glucose or HbA1c, and creatinine levels. However, these vari-
ables were not available in all studies, and some subjects with abnor-
mal values may remain in the final reference cohort.
Variability is inherent in echo. Sourcesof variability havebeen iden-
tified and analyses stratified bymethod of measurement, where pos-
sible. However, we cannot account for the individual variation in
image capture and measurement, which will lead to a degree of
increased noise and variability around the measurements. Similarly,
the type of machine is known; however, machine settings and the
use of harmonic or fundamental imaging is not known. The ideal sam-
pling strategy would be to gather data in a prospective manner after
standardization of image collection and measurement.51 However,
the results of this study can be applied in a wide range of settings,
the majority of which will not have such stringent controls. In this
way, the EchoNoRMAL database may be a fair representation of
‘real world’ echocardiographic measurements.
Discussion
The EchoNoRMAL individual person data meta-analysis will provide
population-based sex-, age-, and ethnic-specific normative reference
values for commonly used echomeasurements of the left heart. The
inclusion of a wide range, and large number, of people should make
these values widely applicable for use in everyday clinical practice.52
Where possible, values will be derived that are relevant to a specific
echo modality (M-mode, 2D, 3D), measurement convention, and
other measurement-specific criteria.
Sex-specific reference ranges have been available for some time,
but not for all measurements, and not in combination with age and
ethnicity. For example, age-related changes in LV diastolic para-
meters were found to differ between Japanese men and women,22
and LVmass differs in young American Blacks comparedwith Ameri-
canWhites,6 but there are no large comparative studies of ethnic dif-
ferences across the range of echo measurements. Few previous
studies have been adequately powered, with adequate numbers of
men and women, over a wide age range, to evaluate these factors.
In a previous systematic review,2 there was sufficient variation in
the range of LV mass in normal cohorts, defined by country of
origin, for us to be confident that reference values formeasurements
of cardiac structure will vary by ethnicity. Many echo measurements
are indexed to a measure of body size to account for differences in
body size and composition. This study will explore different
methods of indexation, the impact among men and women, and
across ethnicity.
Reference ranges can be derived in a number of ways. A common
method is todefine the rangeas anumberof standarddeviations from
the mean of a sample of measurements. This requires values to be
normally distributed, or able to be transformed to be normally dis-
tributed, and values can only be reported per category of age. An ad-
vantage of a regression-based method, such as quantile regression, is
that it allows continuous reference values to be derived across the
range of one or more covariates. Such models require relatively
large data sets compared with what is required for a fully parametric
model; however, the size of the collaboration makes this approach
possible. By fitting independent regression models to segments of
the distribution (e.g. the 5th or 95th centile), quantile regression
can also accommodate changes in variability and allow a greater
understanding of how measurements behave across age. The Euro-
pean Respiratory Society Task Force has recently published multi-
ethnic reference values for spirometry based on data from 33 coun-
tries.53 They also elected to use a regression-based method as it
allowed the changing trend in spirometry values from ages 3 to 95
years to be modelled.
Thebenefits of this studywill not be limited to the reference values
it produces. Given the marked diversity of the world population, it is
likely that this study cannot find appropriate studies from all popula-
tions. This should identify areas where future prospective studies are
necessary. There remains the possibility of updating the analyses if
new normative echo data become available. This study has been
limited to the left heart but could be extended to measurements of
the right heart.
This is a unique international collaboration that has collated echo
and clinical data on 22 404 individuals without clinical CVD to
developwidely applicable reference ranges for use in echo laborator-
ies around the world. It is hypothesized that there will be significant
differences in the range of reference values across different ethnic
groups, even when adjusted for sex and body size. If this hypothesis
is proven correct, it could have significant implications for both the
under- and over-diagnosis of CV abnormalities in different ethnic
groups.
Supplementary data
Supplementary data are available at European Heart Journal – Cardio-
vascular Imaging online.
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